 SOUTH PLAINFIELD, N.J., Aug. 23, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that the Brazilian Health Regulatory Agency, ANVISA Agência Nacional de Vigilância Sanitária, has approved WaylivraTM volanesorsen as the first treatment for familial chylomicronemia syndrome FCS in Brazil. 